Review: The Need for Smoking Cessation Among HIV-Positive Smokers
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Most HIV-positive persons in the U.S. smoke cigarettes. Despite substantial clinical advances in HIV care in the era of highly active antiretroviral therapy (HAART), HIV-positive persons are at high risk of tobacco-related disease and death. HIV-positive persons have complex social, economic, psychiatric, and medical needs that may impact smoking behavior and response to smoking cessation interventions, but there is a dearth of research on smoking cessation interventions tailored to HIV-positive persons. HIV care providers should treat tobacco use with the array of evidence-based smoking cessation treatments available, updating their clinical practice as new data emerge. This article reviews the literature on the health consequences of tobacco use in HIV-positive persons, the treatment of tobacco dependence, and the research to date on smoking cessation interventions in HIV-positive persons, and it presents recommendations for future research and intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Unequal treatment: confronting racial and ethnic disparities in health care
(2003) · Choice Reviews Online · doi:10.5860/choice.40-5843 · Cited by 7,043
Actual causes of death in the United States
McGinnis, J. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180077038 · Cited by 5,480
Physician advice for smoking cessation
Stead, L. F., Buitrago, D., Preciado, N., Sanchez, G., Hartmann-Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000165.pub4 · Cited by 1,955
Jorenby, D. E. (2006) · JAMA · doi:10.1001/jama.296.1.56 · Cited by 1,635 · cited 3×
“…from participation in the clinical trials that demonstrated the efficacy of nicotine replacement therapy, bupropion, or varenicline for smoking cessation (Ahluwalia, Harris, Catley, Okuyemi, & Mayo, 2002; Gonzales et al., 2006; Hurt et al., 1997; Jorenby et al., 2006; Jorenby et al., 1999).”
BackgroundInfluentialTriant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · cited 3×
“Persons with HIV were likely to be excluded from participation in the clinical trials that demonstrated the efficacy of nicotine replacement therapy, bupropion, or varenicline for smoking cessation (Ahluwalia, Harris, Catley, Okuyemi, & Mayo, 2002; Gonzales et al., 2006; Hurt et al., 1997; Jorenby et al., 2006; Jorenb…”
BackgroundClass of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361 · cited 3×
“…from participation in the clinical trials that demonstrated the efficacy of nicotine replacement therapy, bupropion, or varenicline for smoking cessation (Ahluwalia, Harris, Catley, Okuyemi, & Mayo, 2002; Gonzales et al., 2006; Hurt et al., 1997; Jorenby et al., 2006; Jorenby et al., 1999).”
BackgroundInfluentialNicotine replacement therapy for smoking cessation
Silagy, C., Lancaster, T., Stead, L., Mant, D., & Fowler, G. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub2 · Cited by 972
Cited by
Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., Johnson, M., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
Lifson, A. R., Neuhaus, J., Arribas, J. R., van den Berg-Wolf, M., Labriola, A. M., Read, T. R. H., & for the INSIGHT SMART Study Group (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.188664 · Cited by 281
Substance use: impact on adherence and HIV medical treatment
Gonzalez, A., Barinas, J., & O’Cleirigh, C. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0093-5 · Cited by 195
Long-term outcomes of a cell phone–delivered intervention for smokers living with HIV/AIDS
Gritz, E. R., Danysh, H. E., Fletcher, F. E., Tami-Maury, I., Fingeret, M. C., King, R. M., Arduino, R. C., & Vidrine, D. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit349 · Cited by 89
Cropsey, K. L., Hendricks, P. S., Jardin, B., Clark, C. B., Katiyar, N., Willig, J., Mugavero, M., Raper, J. L., Saag, M., & Carpenter, M. J. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.05.003 · Cited by 46
Metadata
- Authors
- Nahvi, S., & Cooperman, N. A.
- Venue
- AIDS Education and Prevention
- Publisher
- Guilford Publications
- Published
- 2009-06
- Volume
- 21
- Issue
- 3_supplement
- Pages
- 14-27
- ISSN
- 0899-9546 (ISSN-L)
- OpenAlex
- W1970573483
- Cited by
- 115
- References
- 16
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review: The Need for Smoking Cessation Among HIV-Positive Smokers. https://app.cochat.ai/papers/10.1521/aeap.2009.21.3_supp.14
- The paper
- Nahvi, S., & Cooperman, N. A. (2009). Review: The Need for Smoking Cessation Among HIV-Positive Smokers. AIDS Education and Prevention. https://doi.org/10.1521/aeap.2009.21.3_supp.14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.